IM Cannabis (IMCC) Cost of Revenue (2020 - 2026)

IM Cannabis has reported Cost of Revenue for 7 years, with the latest figure at $4.4 million in Q2 2026.

• On a quarterly basis, Cost of Revenue fell 34.27% year-over-year to $4.4 million in Q2 2026; TTM through Jun 2026 was $29.0 million, a 1.63% increase from a year earlier, with the FY2025 full-year figure at $32.2 million, down 3.16% from the prior year.
• Cost of Revenue was $4.4 million for Q2 2026 at IM Cannabis, down from $5.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $11.2 million in Q4 2025, with the low at $4.4 million in Q2 2026.
• Average Cost of Revenue over 5 years is $7.6 million, with a median of $7.6 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Cost of Revenue jumped 139.3% in 2022, then tumbled 34.27% in 2026.
• Over 5 years, Cost of Revenue stood at $8.6 million in 2022, then decreased by 18.13% to $7.0 million in 2023, then rose by 8.36% to $7.6 million in 2024, then surged by 46.68% to $11.2 million in 2025, then plunged by 60.69% to $4.4 million in 2026.
• The last three Cost of Revenue figures came in at $4.4 million (Q2 2026), $5.3 million (Q1 2026), and $11.2 million (Q4 2025), per Business Quant data.